

All procedures were performed femorally the retrograde approach was used in 27.8 ± 0.46% of cases. The Japanese CTO score reflecting lesion complexity was 3.56 ± 0.78. The GL is a coaxial, monorail guiding catheter extension delivered through a standard guiding catheter and is available in different sizes.Īlmost all lesions were classified as severely calcified (94.4 ± 0.24%). We examined 18 patients and used the GL catheter to overcome poor support and excessive friction in standardized antegrade and retrograde CTO procedures. The purpose of this study was to assess the feasibility of the GuideLiner (GL) catheter use.
#Guideliner balloon anchor te professional
This device should only be used by a licensed physician (or other health care professional authorized by or under the direction of such physician) possessing adequate instruction in the use of the device, e.g., participation in an Angio-Seal physician instruction program or equivalent.Failure of delivering a stent or a balloon across the target lesion during percutaneous coronary intervention (PCI) of chronic total occlusion (CTO), especially in arteries with calcified tortuous anatomy, is often due to insufficient backup support from the guiding catheter. Possible adverse events for vascular closure devices include, but are not limited to: bleeding or hematoma, AV fistula or pseudoaneurysm, infection, allergic reaction, foreign body reaction, inflammation or edema. The Angio-Seal Vascular Closure Device product family, including the VIP and Evolution platforms, is indicated for use in closing and reducing time to hemostasis of the femoral arterial puncture site in patients who have undergone diagnostic angiography procedures or interventional procedures using an 8 French or smaller procedural sheath for the 8 F Angio-Seal device and a 6 French or smaller procedural sheath for the 6 F Angio-Seal device. The Angio-Seal VIP and Evolution platform devices are also indicated for use to allow patients who have undergone diagnostic angiography to safely ambulate as soon as possible after sheath removal and device placement, as well as to allow patients who have undergone an interventional procedure to safely ambulate after sheath removal and device placement. Per Instructions For Use ASIN0004 revision.The Angio‐Seal hemostatic puncture closure device. Refer to the product labels and package insert for complete warnings, precautions, potential complications, and instructions for use. TAKERU PTCA Balloon Dilatation Catheter.CROSPERIO OTW (0.014") PTA Balloon Dilatation Catheter.CROSPERIO® RX (0.014") PTA Balloon Dilatation Catheter.CROSSTELLA® OTW (0.018") PTA Balloon Dilatation Catheter.CROSSTELLA® RX (0.018") PTA Balloon Dilatation Catheter.METACROSS® OTW (0.035") PTA Balloon Dilatation Catheter.METACROSS® RX (0.035") PTA Balloon Dilatation Catheter.AZUR™ Peripheral HydroCoil Embolization System.


GLIDEWIRE® GT Super-Selective Hydrophilic Coated Guidewire.GLIDEWIRE® Baby-J™ Hydrophilic Coated Guidewire.GLIDEWIRE® Hydrophilic Coated Guidewire.ANGIO-SEAL® EVOLUTION™ Vascular Closure Device.ANGIO-SEAL® VIP Vascular Closure Device.PINNACLE® R/O II HIFLO Introducer Sheath.PINNACLE® R/O II Radiopaque Marker Introducer Sheath.PINNACLE PRECISION ACCESS SYSTEM® Sheath.GLIDESHEATH SLENDER® Hydrophilic Coated Introducer Sheath.GLIDESHEATH™ Hydrophilic Coated Introducer Sheath.
